Phase II Clinical Trial of Combination Chemotherapy With Dexamethasone for Lymphoma in Dogs
2007 ◽
Vol 43
(1)
◽
pp. 27-32
◽
Keyword(s):
Phase Ii
◽
Dogs with histologically confirmed lymphoma were treated with a 14-week induction chemotherapy protocol that included dexamethasone. A phase II clinical trial was done using a standard two-stage design. Complete remission occurred in 21 (88%) dogs, with a median initial progression-free interval of 186 days. Toxicity was mild and self-limiting in the majority of dogs.